SAREPTA THERAPEUTICS INC's ticker is SRPT and the CUSIP is 803607100. A total of 416 filers reported holding SAREPTA THERAPEUTICS INC in Q4 2022. The put-call ratio across all filers is 0.97 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $456,515 | +5.9% | 3,766 | 0.0% | 0.07% | +7.5% |
| Q2 2023 | $431,282 | -16.9% | 3,766 | 0.0% | 0.07% | -23.0% |
| Q1 2023 | $519,068 | +6.4% | 3,766 | 0.0% | 0.09% | -1.1% |
| Q4 2022 | $487,998 | +17.3% | 3,766 | 0.0% | 0.09% | +8.6% |
| Q3 2022 | $416,000 | +46.5% | 3,766 | -0.6% | 0.08% | +47.3% |
| Q2 2022 | $284,000 | -4.1% | 3,789 | 0.0% | 0.06% | +3.8% |
| Q1 2022 | $296,000 | -63.0% | 3,789 | -57.3% | 0.05% | -61.9% |
| Q4 2021 | $799,000 | -2.7% | 8,872 | -0.1% | 0.14% | -12.6% |
| Q3 2021 | $821,000 | +2.9% | 8,884 | -13.4% | 0.16% | +4.6% |
| Q2 2021 | $798,000 | +2.8% | 10,259 | -1.5% | 0.15% | -11.6% |
| Q1 2021 | $776,000 | -75.0% | 10,418 | -42.7% | 0.17% | -75.7% |
| Q4 2020 | $3,105,000 | +26.4% | 18,192 | +4.0% | 0.71% | +22.5% |
| Q3 2020 | $2,456,000 | +60.8% | 17,488 | +83.6% | 0.58% | +39.6% |
| Q2 2020 | $1,527,000 | +64.0% | 9,523 | 0.0% | 0.41% | +28.6% |
| Q1 2020 | $931,000 | -24.2% | 9,523 | 0.0% | 0.32% | +12.6% |
| Q4 2019 | $1,229,000 | +71.4% | 9,523 | 0.0% | 0.29% | +58.9% |
| Q3 2019 | $717,000 | -50.9% | 9,523 | -0.9% | 0.18% | -34.3% |
| Q2 2019 | $1,460,000 | +27.5% | 9,608 | 0.0% | 0.27% | +23.4% |
| Q1 2019 | $1,145,000 | +8.7% | 9,608 | -0.5% | 0.22% | -3.1% |
| Q4 2018 | $1,053,000 | -17.6% | 9,658 | -0.2% | 0.23% | -20.8% |
| Q3 2018 | $1,278,000 | -2.0% | 9,673 | 0.0% | 0.29% | -1.4% |
| Q2 2018 | $1,304,000 | +82.1% | 9,673 | 0.0% | 0.29% | +66.5% |
| Q1 2018 | $716,000 | +32.8% | 9,673 | 0.0% | 0.18% | +38.6% |
| Q4 2017 | $539,000 | +26.2% | 9,673 | +16.1% | 0.13% | +28.3% |
| Q3 2017 | $427,000 | +50.4% | 8,333 | 0.0% | 0.10% | +43.5% |
| Q2 2017 | $284,000 | +16.9% | 8,333 | 0.0% | 0.07% | +9.5% |
| Q1 2017 | $243,000 | +4.3% | 8,333 | 0.0% | 0.06% | -4.5% |
| Q4 2016 | $233,000 | – | 8,333 | – | 0.07% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Ikarian Capital, LLC | 399,400 | $35,962,000 | 5.36% |
| Avoro Capital Advisors LLC | 3,125,000 | $281,406,000 | 4.79% |
| Varenne Capital Partners | 324,661 | $29,236,000 | 4.34% |
| Evolutionary Tree Capital Management, LLC | 96,695 | $8,707,000 | 4.18% |
| Ally Bridge Group (NY) LLC | 120,000 | $10,806,000 | 3.78% |
| Casdin Capital, LLC | 1,350,000 | $121,568,000 | 3.43% |
| Ghost Tree Capital, LLC | 100,000 | $9,005,000 | 3.23% |
| GREAT POINT PARTNERS LLC | 145,405 | $13,094,000 | 2.91% |
| Camber Capital Management LP | 825,000 | $74,291,000 | 2.55% |
| Alpha DNA Investment Management LLC | 17,522 | $1,577,000 | 1.00% |